LATS1/2 antibody
LATS1/2 antibody
![]() LATS1/2 Antibody |
|||
DF7517 | Affbiotech | 200ul | 420 EUR |
![]() Serine/threonine-Protein Kinase LATS1/2 (LATS1/2) Antibody |
|||
20-abx141092 | Abbexa |
|
|
![]() Serine/threonine-Protein Kinase LATS1/2 (LATS1/2) Antibody |
|||
20-abx012918 | Abbexa |
|
|
![]() LATS1 Antibody |
|||
AF7669 | Affbiotech | 200ul | 540 EUR |
![]() LATS1 Antibody |
|||
AF7670 | Affbiotech | 200ul | 540 EUR |
![]() LATS1 Antibody |
|||
AF7671 | Affbiotech | 200ul | 540 EUR |
![]() LATS1 antibody |
|||
70R-18222 | Fitzgerald | 50 ul | 522 EUR |
Description: Rabbit polyclonal LATS1 antibody |
|||
![]() LATS1 antibody |
|||
70R-51351 | Fitzgerald | 100 ul | 292.8 EUR |
Description: Purified Polyclonal LATS1 antibody |
|||
![]() LATS1 antibody |
|||
70R-5683 | Fitzgerald | 50 ug | 560.4 EUR |
Description: Rabbit polyclonal LATS1 antibody |
|||
![]() LATS1 Antibody |
|||
36187-100ul | SAB | 100ul | 302.4 EUR |
![]() lats1 Antibody |
|||
ABD7517 | Lifescience Market | 100 ug | 525.6 EUR |
![]() LATS1 Antibody |
|||
1-CSB-PA830665 | Cusabio |
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
|||
![]() LATS1 Antibody |
|||
1-CSB-PA012769GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
![]() LATS1 Antibody |
|||
1-CSB-PA012769LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF, IP; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:500, IP:1:200-1:2000 |
|||
![]() LATS1 Antibody |
|||
F50049-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
![]() LATS1 Antibody |
|||
F50049-0.4ML | NSJ Bioreagents | 0.4 ml | 322.15 EUR |
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
![]() LATS1 Antibody |
|||
RQ4584 | NSJ Bioreagents | 100ug | 356.15 EUR |
Description: Serine/threonine-protein kinase LATS1 is an enzyme that in humans is encoded by the LATS1 gene. It is mapped to 6q25.1. The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
![]() LATS1/2 Conjugated Antibody |
|||
C33232 | SAB | 100ul | 476.4 EUR |
![]() LATS1/2 Polyclonal Antibody |
|||
ABP51705-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
![]() LATS1/2 Polyclonal Antibody |
|||
ABP51705-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
![]() LATS1/2 Polyclonal Antibody |
|||
ABP51705-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
![]() LATS1/2 Polyclonal Antibody |
|||
ABP59096-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
![]() LATS1/2 Polyclonal Antibody |
|||
ABP59096-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
![]() LATS1/2 Polyclonal Antibody |
|||
ABP59096-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
![]() LATS1/2 Polyclonal Antibody |
|||
ES2704-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
![]() LATS1/2 Polyclonal Antibody |
|||
ES2704-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
![]() LATS1 / LATS2 Antibody |
|||
20-abx325262 | Abbexa |
|
|
![]() LATS1 / LATS2 Antibody |
|||
abx331369-100ul | Abbexa | 100 ul | 510 EUR |
![]() LATS1/LATS2 Antibody |
|||
CSB-PA069135- | Cusabio | each | 402 EUR |
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
![]() LATS1/LATS2 Antibody |
|||
CSB-PA069135-100ul | Cusabio | 100ul | 379.2 EUR |
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
![]() LATS1/LATS2 Antibody |
|||
1-CSB-PA003141 | Cusabio |
|
|
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000 |
|||
![]() LATS1 / 2 (pS909 / 872) Antibody |
|||
abx216529-100ug | Abbexa | 100 ug | 526.8 EUR |
![]() anti- LATS1 antibody |
|||
FNab04708 | FN Test | 100µg | 606.3 EUR |
Description: Antibody raised against LATS1 |
|||
![]() LATS1/LATS2 Polyclonal Antibody |
|||
30393-100ul | SAB | 100ul | 302.4 EUR |
![]() LATS1/LATS2 Polyclonal Antibody |
|||
30393-50ul | SAB | 50ul | 224.4 EUR |
![]() LATS1 Conjugated Antibody |
|||
C36187 | SAB | 100ul | 476.4 EUR |
![]() LATS1/2 (Phospho- Ser909/872) Antibody |
|||
ABF8163 | Lifescience Market | 100 ug | 525.6 EUR |
![]() Anti-LATS1/LATS2 antibody |
|||
STJ11100242 | St John's Laboratory | 100 µl | 332.4 EUR |
![]() LATS1/2 (Phospho-Ser909/872) Antibody |
|||
12514-100ul | SAB | 100ul | 302.4 EUR |
![]() LATS1/2 (Phospho-Ser909/872) Antibody |
|||
12514-50ul | SAB | 50ul | 224.4 EUR |
![]() LATS1 Antibody, HRP conjugated |
|||
1-CSB-PA012769LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
![]() LATS1/2 (Phospho-Thr1079/1041) Antibody |
|||
11736-100ul | SAB | 100ul | 302.4 EUR |
![]() LATS1/2 (Phospho-Thr1079/1041) Antibody |
|||
11736-50ul | SAB | 50ul | 224.4 EUR |
![]() LATS1 / 2 (Phospho-Thr1079 / 1041) Antibody |
|||
20-abx012605 | Abbexa |
|
|
![]() LATS1 Antibody, FITC conjugated |
|||
1-CSB-PA012769LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
![]() LATS1 / LATS2 (pT1079 / 1041) Antibody |
|||
20-abx325183 | Abbexa |
|
|
![]() LATS1 / LATS2 (pT1079 / 1041) Antibody |
|||
abx332955-100ul | Abbexa | 100 ul | 560.4 EUR |
![]() LATS1 Antibody, Biotin conjugated |
|||
1-CSB-PA012769LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
![]() LATS1/LATS2 Polyclonal Conjugated Antibody |
|||
C30393 | SAB | 100ul | 476.4 EUR |
![]() Phospho- LATS1 (Thr1079) Antibody |
|||
ABF3638 | Lifescience Market | 100 ug | 525.6 EUR |
![]() LATS1 (Phospho-Ser909) Antibody |
|||
13033-100ul | SAB | 100ul | 302.4 EUR |
![]() LATS1 (Phospho-Ser909) Antibody |
|||
13033-50ul | SAB | 50ul | 224.4 EUR |
![]() LATS1 (Phospho-Tyr283) Antibody |
|||
13034-100ul | SAB | 100ul | 302.4 EUR |
![]() LATS1 (Phospho-Tyr283) Antibody |
|||
13034-50ul | SAB | 50ul | 224.4 EUR |
![]() LATS1 (Phospho-Thr1079) Antibody |
|||
13032-100ul | SAB | 100ul | 302.4 EUR |
![]() LATS1 (Phospho-Thr1079) Antibody |
|||
13032-50ul | SAB | 50ul | 224.4 EUR |
![]() LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
ABP56962-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041 |
|||
![]() LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
ABP56962-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041 |
|||
![]() LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
ABP56962-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041 |
|||
![]() LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
ES7961-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against LATS1/2 (phospho Thr1079/1041) from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA |
|||
![]() LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
ES7961-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against LATS1/2 (phospho Thr1079/1041) from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA |
|||
![]() LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
ABP59095-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
![]() LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
ABP59095-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
![]() LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
ABP59095-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D | Stressmarq | 0.1ml | 424.8 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is unconjugated. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-A390 | Stressmarq | 0.1ml | 481.2 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 390. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-A488 | Stressmarq | 0.1ml | 480 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 488. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-A565 | Stressmarq | 0.1ml | 480 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 565. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-A594 | Stressmarq | 0.1ml | 480 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 594. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-A633 | Stressmarq | 0.1ml | 480 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 633. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-A655 | Stressmarq | 0.1ml | 480 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 655. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-A680 | Stressmarq | 0.1ml | 480 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 680. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-A700 | Stressmarq | 0.1ml | 480 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 700. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-ALP | Stressmarq | 0.1ml | 472.8 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Alkaline Phosphatase. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-APC | Stressmarq | 0.1ml | 478.8 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to APC . |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-APCCY7 | Stressmarq | 0.1ml | 565.2 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to APC/Cy7. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-BI | Stressmarq | 0.1ml | 475.2 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Biotin. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-DY350 | Stressmarq | 0.1ml | 570 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 350. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-DY405 | Stressmarq | 0.1ml | 542.4 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 405. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-DY488 | Stressmarq | 0.1ml | 518.4 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 488. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-DY594 | Stressmarq | 0.1ml | 523.2 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 594. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-DY633 | Stressmarq | 0.1ml | 511.2 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 633. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-FITC | Stressmarq | 0.1ml | 470.4 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to FITC. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-HRP | Stressmarq | 0.1ml | 465.6 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to HRP. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-P594 | Stressmarq | 0.1ml | 488.4 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to PE/ATTO 594. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-PCP | Stressmarq | 0.1ml | 478.8 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to PerCP. |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-RPE | Stressmarq | 0.1ml | 476.4 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to RPE . |
|||
![]() Antibody for Human LATS1 (pSer909) |
|||
SPC-1005D-STR | Stressmarq | 0.1ml | 477.6 EUR |
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Streptavidin. |
|||
![]() LATS1 (Phospho-Ser909) Conjugated Antibody |
|||
C13033 | SAB | 100ul | 476.4 EUR |
![]() LATS1 (Phospho-Tyr283) Conjugated Antibody |
|||
C13034 | SAB | 100ul | 476.4 EUR |
![]() LATS1 (Phospho-Thr1079) Conjugated Antibody |
|||
C13032 | SAB | 100ul | 476.4 EUR |
![]() Phospho-LATS1/LATS2 (T1079/1041) Antibody |
|||
1-CSB-PA070231 | Cusabio |
|
|
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (T1079/1041). Recognizes Phospho-LATS1/LATS2 (T1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/20000 |
|||
![]() LATS1/2 (Phospho-Ser909/872) Polyclonal Conjugated Antibody |
|||
C12514 | SAB | 100ul | 476.4 EUR |
![]() Phospho-LATS1/LATS2 (Thr1079/1041) Antibody |
|||
CSB-PA905508- | Cusabio | each | 402 EUR |
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
![]() Phospho-LATS1/LATS2 (Thr1079/1041) Antibody |
|||
CSB-PA905508-100ul | Cusabio | 100ul | 434.4 EUR |
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
![]() LATS1/2 (Phospho-Thr1079/1041) Polyclonal Conjugated Antibody |
|||
C11736 | SAB | 100ul | 476.4 EUR |
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
20-abx312862 | Abbexa |
|
|
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
abx234708-100ug | Abbexa | 100 ug | 577.2 EUR |
![]() Large Tumor Suppressor Kinase 1 (lats1) Antibody |
|||
abx216530-100ug | Abbexa | 100 ug | 526.8 EUR |
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
20-abx210537 | Abbexa |
|
|
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
20-abx113445 | Abbexa |
|
|
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
abx033135-400ul | Abbexa | 400 ul | 627.6 EUR |
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
abx033135-80l | Abbexa | 80 µl | 343.2 EUR |
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
20-abx007804 | Abbexa |
|
|
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody (HRP) |
|||
20-abx312863 | Abbexa |
|
|
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody (FITC) |
|||
20-abx312864 | Abbexa |
|
|
![]() Large Tumor Suppressor Kinase 1 (LATS1) Antibody (Biotin) |
|||
20-abx312865 | Abbexa |
|
|
![]() LATS1 / 2 Blocking Peptide |
|||
20-abx061790 | Abbexa |
|
|
![]() lats1/2 Blocking Peptide |
|||
DF7517-BP | Affbiotech | 1mg | 234 EUR |
![]() Anti-phospho-LATS1-S909/LATS2-S872 antibody |
|||
STJ11101017 | St John's Laboratory | 50 µl | 471.6 EUR |
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
![]() Anti-phospho-LATS1-S909/LATS2-S872 antibody |
|||
STJ11101039 | St John's Laboratory | 100 µl | 471.6 EUR |
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
![]() Anti-phospho-LATS1-T1079/LATS2-T1041 antibody |
|||
STJ11101018 | St John's Laboratory | 50 µl | 471.6 EUR |
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
![]() Anti-phospho-LATS1-T1079/LATS2-T1041 antibody |
|||
STJ11101047 | St John's Laboratory | 100 µl | 471.6 EUR |
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
![]() LATS1 siRNA |
|||
20-abx922294 | Abbexa |
|
|
![]() LATS1 siRNA |
|||
20-abx922295 | Abbexa |
|
|
![]() LATS1/LATS2 Rabbit pAb |
|||
A18286-100ul | Abclonal | 100 ul | 369.6 EUR |
![]() LATS1/LATS2 Rabbit pAb |
|||
A18286-200ul | Abclonal | 200 ul | 550.8 EUR |
![]() LATS1/LATS2 Rabbit pAb |
|||
A18286-20ul | Abclonal | 20 ul | 219.6 EUR |
![]() LATS1/LATS2 Rabbit pAb |
|||
A18286-50ul | Abclonal | 50 ul | 267.6 EUR |
LATS1/2 antibody